BROWSE·page 853 of 1521

Browse EX-10 agreements

18,243 total material contract exhibits.


EXHIBIT 10.1

SUPERNUS PHARMACEUTICALS, INC.

VOTING AGREEMENT

This VOTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2026, by and between Indivior Pharmaceuticals, Inc., a Delaware corporation (“Indivior”) and the undersigned stockholder (the “Stockholder”) of Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Supernus”).

WITNESSETH:

WHEREAS, contemporaneously with the execution of this Agreement, Supernus, Indivior and Artemis Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Indivior (“Merger Sub”) are entering into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”);

WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Supernus (the “Merger”) with Supernus continuing as the surviving corporation and a wholly owned Subsidiary of Indivior;

…

EX-10.1·425·CIK 1356576·ACC 0001104659-26-089426·Filed Aug 03, 2026, 06:45 ET

EXHIBIT 10.3

SUPERNUS PHARMACEUTICALS, INC.

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into this 1st day of August, 2026, by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jack Khattar (the “Executive”). This Agreement shall become effective only upon, and shall be contingent upon, the consummation of the Merger (as defined below). If the Merger is not consummated, this Agreement shall be null and void and of no force or effect.

WHEREAS, the Executive and the Company originally entered into an amended and restated employment agreement dated February 29, 2012, as amended through the date hereof;

WHEREAS, the Company is merging with and into Artemis Merger Sub Inc., a subsidiary of Indivior Pharmaceuticals Inc. (“Indivior”), pursuant to that certain Agreement and Plan of Merger dated August 1, 2026 (the “Merger Agreement” and such merger, the “Merger”), pursuant to which Merger, the Company shall be the surviving corporation;

…

EX-10.3·425·CIK 1356576·ACC 0001104659-26-089426·Filed Aug 03, 2026, 06:45 ET

EXHIBIT 10.2

SUPERNUS PHARMACEUTICALS, INC.

VOTING AGREEMENT

This VOTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2026, by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (“Supernus”) and the undersigned stockholder (the “Stockholder”) of Indivior Pharmaceuticals, Inc., a Delaware corporation (“Indivior”).

WITNESSETH:

WHEREAS, contemporaneously with the execution of this Agreement, Supernus, Indivior and Artemis Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Indivior (“Merger Sub”) are entering into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”);

WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Supernus (the “Merger”) with Supernus continuing as the surviving corporation and a wholly owned Subsidiary of Indivior;

…

EX-10.2·8-K·CIK 1356576·ACC 0001104659-26-089425·Filed Aug 03, 2026, 06:43 ET

EXHIBIT 10.1

SUPERNUS PHARMACEUTICALS, INC.

VOTING AGREEMENT

This VOTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2026, by and between Indivior Pharmaceuticals, Inc., a Delaware corporation (“Indivior”) and the undersigned stockholder (the “Stockholder”) of Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Supernus”).

WITNESSETH:

WHEREAS, contemporaneously with the execution of this Agreement, Supernus, Indivior and Artemis Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Indivior (“Merger Sub”) are entering into an Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”);

WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Supernus (the “Merger”) with Supernus continuing as the surviving corporation and a wholly owned Subsidiary of Indivior;

…

EX-10.1·8-K·CIK 1356576·ACC 0001104659-26-089425·Filed Aug 03, 2026, 06:43 ET

EXHIBIT 10.3

SUPERNUS PHARMACEUTICALS, INC.

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into this 1st day of August, 2026, by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jack Khattar (the “Executive”). This Agreement shall become effective only upon, and shall be contingent upon, the consummation of the Merger (as defined below). If the Merger is not consummated, this Agreement shall be null and void and of no force or effect.

WHEREAS, the Executive and the Company originally entered into an amended and restated employment agreement dated February 29, 2012, as amended through the date hereof;

WHEREAS, the Company is merging with and into Artemis Merger Sub Inc., a subsidiary of Indivior Pharmaceuticals Inc. (“Indivior”), pursuant to that certain Agreement and Plan of Merger dated August 1, 2026 (the “Merger Agreement” and such merger, the “Merger”), pursuant to which Merger, the Company shall be the surviving corporation;

…

EX-10.3·8-K·CIK 1356576·ACC 0001104659-26-089425·Filed Aug 03, 2026, 06:43 ET

PARK HA BIOLOGICAL TECHNOLOGY CO., LTD.

2026 SHARE INCENTIVE PLAN

1. Purpose. The purpose of the Park Ha Biological Technology Co., Ltd. (the “Company”) 2026 Share Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, managers, employees, consultants and advisors (and prospective directors, officers, managers, employees, consultants and advisors) of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, which may (but need not) be measured by reference to the value of its Class A Ordinary Shares, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company’s shareholders.

2. Definitions. The following definitions shall be applicable throughout this Plan:

…

EX-10.1·S-8·CIK 1986247·ACC 0001213900-26-084234·Filed Aug 03, 2026, 06:20 ET

PROFESSIONAL SERVICES AGREEMENT (PSA)_________________PSA No. _______________

This Professional Services Agreement (PSA) is by and between WhiteFiber, Inc. having a principal place of business at: 31 Hudson Yards, Suite 1130, New York, New York 10001 (hereinafter referred to as the “CLIENT”), and Rasterwerk LLC, a Maryland limited liability company, having a principal place of business at**______________________**, (hereinafter referred to as “Rasterwerk”).

This Agreement sets forth the terms and conditions under which Rasterwerk will provide services to CLIENT for professional services made available by Rasterwerk to CLIENT.

1.  SERVICES. Rasterwerk agrees to perform and CLIENT agrees to pay Rasterwerk for professional services as may be described in one or more Engagement Authorizations signed by the parties (hereinafter the “Services”). Services may be performed at either the CLIENT site or at Rasterwerk’s .

…

EX-10.8·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is entered into effective as of August 1, 2026 (the “Effective Date”) by and between WhiteFiber, Inc., incorporated under the laws of the Cayman Islands (the “Company”), and Justin Zhu (“Executive”). For purposes of this Agreement, the Company and Executive are each a “party” and, collectively, the “parties”. In consideration of the mutual promises and covenants contained in this Agreement, the parties agree as follows:

1. Agreement to Employ. The Company desires to secure the services of Executive as its Chief Financial Officer (“CFO”). The Company and Executive desire to enter into this Agreement to, among other things, set forth the terms of Executive’s employment with the Company.

…

EX-10.2·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET

AMENDMENT TO
DIRECTOR AGREEMENT

AMENDMENT TO DIRECTOR AGREEMENT dated as of July 30, 2026, with an effective date of August 1, 2026 (the “Effective Date”) by and between WhiteFiber, Inc., a Cayman Islands exempted company, with its principal business at 31 Hudson Yards, Floor 11, Suite 30, New York, New York 10001 (the “Company”) and Mr. Pruitt Hall, with an address at [Intentionally left blank] (the “Director”).

** **

W I T N E S S E T H :

** **

WHEREAS, the Company and the Director entered into a Director Agreement dated as of May 5, 2025 (the “Agreement”); and

** **

WHEREAS, the Agreement provided for the Directorship Term to be one (1) year from the commencement of trading of the Company’s Ordinary Shares on the Nasdaq Capital Market.

** **

NOW, THEREFORE, in consideration of the mutual premises and covenants and agreements contained herein and for other good and valuable consideration by each of the parties, the parties hereby agree as follows:

…

EX-10.9·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET

ADVISORY SERVICES AGREEMENT

THIS AGREEMENT is dated the 30th day of July, 2026, and shall become effective as of the 1st day of August, 2026: (the “Effective Date”)

BETWEEN:

WHITEFIBER, INC., a company organized under the laws of the Cayman Islands, with its principal place of business at 31 Hudson Yards, 11th Floor, Suite 30, New York, NY 10001 (the “Company”)

- and -

ERKE HUANG. With an address at 6A, 3 Macdonnel Road, Mid-Levels, Hong Kong (the “Advisor”)

WHEREAS: The Company and the Advisor wish to set out the terms and conditions pursuant to which the Company will engage the services of the Advisor, and the Advisor will provide such services.

NOW THEREFORE in consideration of the mutual covenants and agreements contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1. Engagement of Services

…

EX-10.1·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET

** **

Indemnification Agreement

** **

THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of August 1st, 2026, by and between WhiteFiber, Inc., incorporated under the laws of the Cayman Islands (the “Company”) and Justin Zhu (“Indemnitee”).

** **

RECITALS

** **

WHEREAS, the Company desires to employ Indemnitee as its Chief Financial Officer (“CFO”);

** **

WHEREAS, Indemnitee would not be willing to accept such employment in the absence of this Agreement;

** **

WHEREAS, the Company is willing to provide this Agreement in order to induce Indemnitee to accept such employment as the Company’s CFO and to enter into that certain Employment Agreement dated the date hereof between the Company and Indemnitee;

** **

…

EX-10.3·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET

** **

DIRECTOR AGREEMENT

This DIRECTOR AGREEMENT is made as of this 30th day of July 2026 (the “Agreement”), by and between WhiteFiber, Inc., a company organized under the laws of the Cayman Islands (the “Company”) and Samir Tabar, an individual with his principal address at [Intentionally left blank] (the “Director”).

WHEREAS, the Company wishes to appoint the Director as a member of the Board of Directors of the Company effective August 1, 2026 (the “Effective Date”) and enter into this agreement with the Director with respect to such appointment; and

WHEREAS, the Director wishes to accept such appointment and to serve the Company on the terms set forth herein, and in accordance with, the provisions of this Agreement.

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

…

EX-10.4·8-K·CIK 2042022·ACC 0001213900-26-084223·Filed Aug 03, 2026, 06:13 ET